PARP1 and Miyoshi myopathy: Indeed, proteasome inhibitors block Fanconi anemia and homologous recombination pathways, rendering MM cells addict on BER initiated by PARP1/2-mediated Poly(ADP-ribosyl)ation of proteins[38].